China · Delayed Price · Currency is CNY Jiangsu Nanfang Medical Statistics
Total Valuation
SHA:603880 has a market cap or net worth of CNY 2.24 billion. The enterprise value is 2.62 billion.
| Market Cap | 2.24B |
| Enterprise Value | 2.62B |
Important Dates
The last earnings date was Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603880 has 289.04 million shares outstanding. The number of shares has decreased by -0.52% in one year.
| Current Share Class | 289.04M |
| Shares Outstanding | 289.04M |
| Shares Change (YoY) | -0.52% |
| Shares Change (QoQ) | -3.42% |
| Owned by Insiders (%) | 52.42% |
| Owned by Institutions (%) | 3.64% |
| Float | 137.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.83 |
| PB Ratio | 12.70 |
| P/TBV Ratio | 16.99 |
| P/FCF Ratio | 33.25 |
| P/OCF Ratio | 27.04 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -26.49 |
| EV / Sales | 4.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 38.94 |
Financial Position
The company has a current ratio of 0.48, with a Debt / Equity ratio of 2.52.
| Current Ratio | 0.48 |
| Quick Ratio | 0.30 |
| Debt / Equity | 2.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.60 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -43.32% and return on invested capital (ROIC) is -9.94%.
| Return on Equity (ROE) | -43.32% |
| Return on Assets (ROA) | -3.63% |
| Return on Invested Capital (ROIC) | -9.94% |
| Return on Capital Employed (ROCE) | -22.45% |
| Weighted Average Cost of Capital (WACC) | 4.79% |
| Revenue Per Employee | 687,859 |
| Profits Per Employee | -116,333 |
| Employee Count | 850 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.91 |
Taxes
In the past 12 months, SHA:603880 has paid 7.63 million in taxes.
| Income Tax | 7.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.13% in the last 52 weeks. The beta is 0.27, so SHA:603880's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +44.13% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 6.58 |
| Relative Strength Index (RSI) | 70.90 |
| Average Volume (20 Days) | 7,676,332 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603880 had revenue of CNY 584.68 million and -98.88 million in losses. Loss per share was -0.34.
| Revenue | 584.68M |
| Gross Profit | 22.85M |
| Operating Income | -56.69M |
| Pretax Income | -90.56M |
| Net Income | -98.88M |
| EBITDA | -13.13M |
| EBIT | -56.69M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 65.48 million in cash and 443.85 million in debt, with a net cash position of -378.37 million or -1.31 per share.
| Cash & Cash Equivalents | 65.48M |
| Total Debt | 443.85M |
| Net Cash | -378.37M |
| Net Cash Per Share | -1.31 |
| Equity (Book Value) | 176.20M |
| Book Value Per Share | 0.61 |
| Working Capital | -343.42M |
Cash Flow
In the last 12 months, operating cash flow was 82.73 million and capital expenditures -15.45 million, giving a free cash flow of 67.28 million.
| Operating Cash Flow | 82.73M |
| Capital Expenditures | -15.45M |
| Depreciation & Amortization | 43.56M |
| Net Borrowing | -40.22M |
| Free Cash Flow | 67.28M |
| FCF Per Share | 0.23 |
Margins
Gross margin is 3.91%, with operating and profit margins of -9.70% and -16.91%.
| Gross Margin | 3.91% |
| Operating Margin | -9.70% |
| Pretax Margin | -15.49% |
| Profit Margin | -16.91% |
| EBITDA Margin | -2.25% |
| EBIT Margin | -9.70% |
| FCF Margin | 11.51% |
Dividends & Yields
SHA:603880 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.52% |
| Shareholder Yield | 0.52% |
| Earnings Yield | -4.42% |
| FCF Yield | 3.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 21, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 21, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |